ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee
ZYUS Life Sciences Corp. ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, is pleased to announce that Wayne Brownlee, former Vice-President and Chief Financial Officer (“CFO”) of both Potash Corporation of Saskatchewan Inc. (“PotashCorp”) and Nutrien Ltd. (“Nutrien”), has agreed to accept an appointment to ZYUS’ Board of Directors.
- ZYUS Life Sciences Corp. ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, is pleased to announce that Wayne Brownlee, former Vice-President and Chief Financial Officer (“CFO”) of both Potash Corporation of Saskatchewan Inc. (“PotashCorp”) and Nutrien Ltd. (“Nutrien”), has agreed to accept an appointment to ZYUS’ Board of Directors.
- Mr. Brownlee brings a wealth of knowledge, experience and expertise to his new role with ZYUS.
- In 1989, Mr. Brownlee joined PotashCorp when it was a Crown corporation and was a catalyst for the expansion and development throughout its acquisition activity.
- “We are extremely pleased to welcome Wayne Brownlee to ZYUS’ Board of Directors,” said Brent Zettl, President and Chief Executive Officer of the Company.